On the 14th November, SpacePharma SA (SP) and SAB Launch Services Srl (SAB-LS) signed the LSA for the Launch Services of DIDO-3, the Nanosatellite developed by SpacePharma to perform biological experiment under Microgravity field. The Cubesat is part of the Institutional Aggregate managed by SAB-LS